Clinical Trials

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients with Refractory Advanced/Metastatic Colorectal Cancer (FRUITION)

Cancer Type

Colorectal Cancer

ClinicalTrials.gov Identifier

NCT06992258

Principal Investigator

Sukeshi Patel Arora, MD

For more information about this study
View Details

About This Study

This will be a multi-center, randomized phase II trial of fruquintinib + TAS-102 as compared to fruquintinib.